FDAnews
www.fdanews.com/articles/133953-orexigen-rejection-kills-obesity-drug-field

Orexigen Rejection Kills Obesity Drug Field

February 2, 2011
The Food and Drug Administration rejected Orexigen’s weight loss pill Contrave, the third of three obesity drugs to be denied approval since October. The field of obesity drugs is effectively dead.
Forbes